In the Phase 2 trial published in the New England Journal of Medicine in 2023, investigators assigned participants to placebo or to weekly amounts of 1 mg, 4 mg, 8 mg, or 12 mg over 48 weeks investigational quantities given under supervision
In a randomized clinical trial published in JAMA Psychiatry, semaglutide reduced alcohol craving and improved some drinking outcomes versus placebo in adults with alcohol use disorder
Body composition, hepatic fat, metabolic, and safety outcomes of tesamorelin in HIV-associated lipodystrophy
Keep the dose button pressed down, keep the needle under the skin, and slowly count to 6 to make sure the full dose is injected
For these reasons, a growing number of clinicians view GLP-1 medications as an essential ingredient in a well-rounded metabolic health optimization program, regardless of whether or not the patients in the program technically meet criteria for diabetes or obesity the conditions for which the FDA originally approved them
The 12mg cohort achieved the highest mean body weight reduction at -24.2% exceeding all published results for semaglutide (approximately -16% in the STEP trials) and tirzepatide (approximately -22.5% in SURMOUNT-1) at their respective maximum doses
